Skip to content
GLP-1 Savers
Menu
Ranked #194 · Watch List

NexLife review

NexLife is a LegitScript-certified telehealth platform selling compounded semaglutide from $139 and tirzepatide from $169 a month, with a $119 rate available to anyone committing to twelve months.

By Grant Ashford, Founder & Pricing Editor

Est. first month

From $139/mo

Save ~90% vs brand-name

From $139/mo (as low as $119/mo on a 12-month plan, compounded)

FDA warning letter. The FDA issued Nexlife Inc. dba Nexlife a warning letter in June 2026. Check it on the FDA database.

Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. Two figures, and the gap between them is a year. NexLife's weight-loss page starts semaglutide at $139 and tirzepatide at $169 a month; the $119 headline elsewhere on the site carries an asterisk reading "on a 12-month plan". The row previously carried $165 and $215, which match neither.

How much does NexLife cost?

The price NexLife publishes is From $139/mo (as low as $119/mo on a 12-month plan, compounded). Tirzepatide is listed at From $169/mo (compounded). We flag this one to watch: confirm the ongoing rate with NexLife before you count on it, because a low first month can step up afterward. That works out about 90% under our ~$1,349/mo brand-name cash reference.

Semaglutide
From $139/mo (as low as $119/mo on a 12-month plan, compounded)
Tirzepatide
From $169/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

NexLife scored on our six published factors. See the methodology.

Lowest Real Price79/100
No Teaser-Rate Bait72/100
Nationwide Availability45/100
Both Molecules92/100
Easy Cancellation58/100
Reputation73/100

Why it's a deal

  • Publishes the month-to-month rate and the twelve-month rate separately rather than showing only the lower one
  • The subscription is stated to include provider consultations, the treatment and on-demand medical support with no hidden fees
  • All plans are FSA and HSA eligible, with free expedited delivery
  • Same-day messaging with the clinical team rather than a ticket queue

Read the fine print

  • The $119 figure that appears across the site needs a twelve-month commitment; the month-to-month rate is $139
  • The states served are not publicly disclosed
  • GLP-1s sit beside hormone-optimization and longevity lines rather than being the sole focus
  • Compounded only — no FDA-approved brand-name route

The bottom line

Best for: Someone comparing month-to-month rates who will read which figure carries the asterisk. NexLife is a LegitScript-certified telehealth platform selling compounded semaglutide from $139 and tirzepatide from $169 a month, with a $119 rate available to anyone committing to twelve months.

Ranked #194 of 427 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to NexLife, out of 426 others we track.

Shopping NexLife against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs NexLife, and every program that undercuts or outscores it — starting with MediRX, the closest match on score — is ranked on the NexLife alternatives ranking.

More programs we track (24)

396 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from NexLife's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on NexLife's site. Not medical advice; see our disclosure.

See every program ranked by price →

← Back to all deals